Matches in SemOpenAlex for { <https://semopenalex.org/work/W1891831617> ?p ?o ?g. }
Showing items 1 to 93 of
93
with 100 items per page.
- W1891831617 endingPage "2140" @default.
- W1891831617 startingPage "2134" @default.
- W1891831617 abstract "To improve current adjuvant results in high-risk breast cancer, in February 1982 we activated a prospective randomized trial using both intravenous cyclophosphamide, methotrexate, and fluorouracil (CMF) and Adriamycin (doxorubicin; Farmitalia-Carlo Erba, Milan, Italy) involving patients with resectable mammary carcinoma and more than three positive axillary lymph nodes. The objective of the study was to assess the effectiveness of four courses of Adriamycin followed by eight courses of CMF versus two courses of CMF alternated with one course of Adriamycin for a total of 12 courses. All drug courses were recycled every 3 weeks. Rather than temporarily reducing doses in the event of myelosuppression on the planned day of treatment, drug administration was delayed for 1 to 2 weeks. At a median follow-up of 59 months, treatment outcome was significantly superior for patients who received Adriamycin followed by CMF (Adriamycin----CMF) than for those given alternating regimens (CMF/Adriamycin). The 5-year relapse-free survival was superior post-Adriamycin----CMF (61%) compared with post-CMF/Adriamycin administration (38%; P = .001). The corresponding figures for the 5-year total survival were 78% and 62%, respectively (P = .005). The benefit of Adriamycin----CMF was observed in all patient subsets. Treatment was fairly well tolerated, and we documented only one case of fatal congestive heart failure in a patient who received postoperative irradiation to the left breast in addition to Adriamycin. Present findings indicate that in women with extensive nodal involvement, Adriamycin----CMF yielded superior results compared with CMF/Adriamycin." @default.
- W1891831617 created "2016-06-24" @default.
- W1891831617 creator A5023558260 @default.
- W1891831617 creator A5040934952 @default.
- W1891831617 creator A5041398398 @default.
- W1891831617 creator A5061761089 @default.
- W1891831617 date "1991-12-01" @default.
- W1891831617 modified "2023-09-25" @default.
- W1891831617 title "Adjuvant chemotherapy with doxorubicin plus cyclophosphamide, methotrexate, and fluorouracil in the treatment of resectable breast cancer with more than three positive axillary nodes." @default.
- W1891831617 cites W1842248410 @default.
- W1891831617 cites W1863343593 @default.
- W1891831617 cites W1863712471 @default.
- W1891831617 cites W1979300931 @default.
- W1891831617 cites W2001584892 @default.
- W1891831617 cites W2038252730 @default.
- W1891831617 cites W2055310422 @default.
- W1891831617 cites W2063561065 @default.
- W1891831617 cites W2093247251 @default.
- W1891831617 cites W2226205378 @default.
- W1891831617 cites W2335332412 @default.
- W1891831617 cites W2338983050 @default.
- W1891831617 cites W2413853954 @default.
- W1891831617 cites W2901368272 @default.
- W1891831617 cites W850470413 @default.
- W1891831617 doi "https://doi.org/10.1200/jco.1991.9.12.2134" @default.
- W1891831617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/1960555" @default.
- W1891831617 hasPublicationYear "1991" @default.
- W1891831617 type Work @default.
- W1891831617 sameAs 1891831617 @default.
- W1891831617 citedByCount "150" @default.
- W1891831617 countsByYear W18918316172012 @default.
- W1891831617 countsByYear W18918316172013 @default.
- W1891831617 countsByYear W18918316172015 @default.
- W1891831617 countsByYear W18918316172016 @default.
- W1891831617 countsByYear W18918316172017 @default.
- W1891831617 countsByYear W18918316172018 @default.
- W1891831617 countsByYear W18918316172019 @default.
- W1891831617 countsByYear W18918316172020 @default.
- W1891831617 countsByYear W18918316172021 @default.
- W1891831617 countsByYear W18918316172022 @default.
- W1891831617 crossrefType "journal-article" @default.
- W1891831617 hasAuthorship W1891831617A5023558260 @default.
- W1891831617 hasAuthorship W1891831617A5040934952 @default.
- W1891831617 hasAuthorship W1891831617A5041398398 @default.
- W1891831617 hasAuthorship W1891831617A5061761089 @default.
- W1891831617 hasConcept C121608353 @default.
- W1891831617 hasConcept C126322002 @default.
- W1891831617 hasConcept C141071460 @default.
- W1891831617 hasConcept C143998085 @default.
- W1891831617 hasConcept C2776694085 @default.
- W1891831617 hasConcept C2776755627 @default.
- W1891831617 hasConcept C2777649267 @default.
- W1891831617 hasConcept C2777863537 @default.
- W1891831617 hasConcept C2780456651 @default.
- W1891831617 hasConcept C2781059491 @default.
- W1891831617 hasConcept C2781303535 @default.
- W1891831617 hasConcept C530470458 @default.
- W1891831617 hasConcept C71924100 @default.
- W1891831617 hasConceptScore W1891831617C121608353 @default.
- W1891831617 hasConceptScore W1891831617C126322002 @default.
- W1891831617 hasConceptScore W1891831617C141071460 @default.
- W1891831617 hasConceptScore W1891831617C143998085 @default.
- W1891831617 hasConceptScore W1891831617C2776694085 @default.
- W1891831617 hasConceptScore W1891831617C2776755627 @default.
- W1891831617 hasConceptScore W1891831617C2777649267 @default.
- W1891831617 hasConceptScore W1891831617C2777863537 @default.
- W1891831617 hasConceptScore W1891831617C2780456651 @default.
- W1891831617 hasConceptScore W1891831617C2781059491 @default.
- W1891831617 hasConceptScore W1891831617C2781303535 @default.
- W1891831617 hasConceptScore W1891831617C530470458 @default.
- W1891831617 hasConceptScore W1891831617C71924100 @default.
- W1891831617 hasIssue "12" @default.
- W1891831617 hasLocation W18918316171 @default.
- W1891831617 hasLocation W18918316172 @default.
- W1891831617 hasOpenAccess W1891831617 @default.
- W1891831617 hasPrimaryLocation W18918316171 @default.
- W1891831617 hasRelatedWork W1966841381 @default.
- W1891831617 hasRelatedWork W1989798994 @default.
- W1891831617 hasRelatedWork W2003378875 @default.
- W1891831617 hasRelatedWork W2035712195 @default.
- W1891831617 hasRelatedWork W2036067444 @default.
- W1891831617 hasRelatedWork W2091205535 @default.
- W1891831617 hasRelatedWork W2147292731 @default.
- W1891831617 hasRelatedWork W2167558728 @default.
- W1891831617 hasRelatedWork W4212821134 @default.
- W1891831617 hasRelatedWork W4241902883 @default.
- W1891831617 hasVolume "9" @default.
- W1891831617 isParatext "false" @default.
- W1891831617 isRetracted "false" @default.
- W1891831617 magId "1891831617" @default.
- W1891831617 workType "article" @default.